[Drug-induced microscopic colitis].
Kummer
O
O
Klinische Pharmakologie & Toxikologie, Universitätsspital Basel. kummero@uhbs.ch
Novakova
K
K
Burkard
T
T
Hammann
F
F
Krähenbühl
S
S
Bodmer
M
M
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000009:adverse effects*; D000368:Aged; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D001706:Biopsy; D046728:Colitis, Microscopic / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D003106:Colon / Q000473:pathology; D003113:Colonoscopy; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D064747:Lansoprazole
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D064747:Lansoprazole